New deal inked to space test meta-optical surfaces

European Space Agency funds project

2023-05-15

(Press-News.org) A new engineering study has been commissioned by the European Space Agency (under PECS, the Program for European Cooperating States), to prove the reliability of meta-optical elements for space use in a collaboration between the ESA, Bulgarian start-up company LaboraXpert and TMOS, the Australian Research Council Centre of Excellence for Transformative Meta-Optical Systems.

In the first study of its kind, it will determine whether meta-optical components can withstand the pressures of space launch and prolonged exposure to the space environment.

TMOS Centre Director Prof. Dragomir Neshev says, “The demand for Earth observation data is growing, yet the industry still faces the challenge of size and weight constraints when sending a payload into space. Meta-optics will allow for the simultaneous advancement of the functionality and miniaturization of remote sensing systems. This study will provide information towards the development of robust space applications using meta-material optical elements.”

LaboraXpert’s CEO, Dr. Vesselin Vassilev, says, “Space is a booming industry that relies on developing advanced technologies and solutions in various domains. It offers a great opportunity to demonstrate the performance of the advanced imaging systems our company is developing. TMOS’s research goals align closely with our company’s determination to provide ground breaking multi-spectral sensors for space and other applications. We hope this is the first step of a longer term applied R&D collaboration.”

Prof. Neshev says, “We believe meta-optics will enable a new set of innovative applications because of its ability to miniaturise complex optical devices and provide additional embedded functionality of optical systems. Meta-optics significantly outperforms bulky traditional optics in its low size, weight and power requirements, which will have a great benefit for the space industry. Space environment applications are tough ones to succeed in. This project with LaboraXpert and ESA is an indication of the quality cutting-edge technology TMOS is pioneering.”

Both Prof.Neshev and Dr. Vassilev hope this project foreshadows a deepening of advanced industry and research collaboration between Europe and Australia.

For more information about this project, please contact connect@tmos.org.au

END

[Attachments] See images for this press release:

New deal inked to space test meta-optical surfaces 2

ELSE PRESS RELEASES FROM THIS DATE:

Scientists create first humanised mouse model for rare genetic disease

2023-05-15

Mice with a defected human gene responsible for a rare genetic disease, called congenital adrenal hyperplasia, have been developed for the first time. The achievement, presented at the 25th European Congress of Endocrinology, may help to develop new therapies for people with the most common type of congenital adrenal hyperplasia. Congenital adrenal hyperplasia (CAH) is a group of inherited conditions, which affects about 1 in 15,000 births. In the most common form, called 21-hydroxylase deficiency, mutations in the CYP21A2 gene cause the adrenal glands ...

Novel sustainable electrochemical method converts carbon dioxide into carbonaceous materials

2023-05-15

Carbon dioxide (CO2) is a major greenhouse gas emitted through various types of human activities. In an effort to decrease humanity’s carbon footprint, scientists and policymakers across the globe are continuously trying to explore new methods for reducing atmospheric CO2 emissions and converting them into useful forms. In this regard, the electrochemical method of reducing CO2 to other carbonaceous forms like carbon monoxide, alcohols and hydrocarbon has gained considerable attention. Against this ...

Managing menopause: Hormone therapy is back

2023-05-15

Hot flashes, night sweats and sleep disturbances are common symptoms of menopause that can affect health, quality of life and work productivity. A new review published in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.221438 recommends menopausal hormone therapy, historically known as hormone replacement therapy (HRT), as first-line treatment in people without risk factors. Menopausal symptoms may occur up to 10 years before the last menstrual period and can last more than 10 years, with negative effects for many people. "Menopause and perimenopause can be associated with distressing ...

Can’t find your phone? There’s a robot for that

2023-05-15

Engineers at the University of Waterloo have discovered a new way to program robots to help people with dementia locate medicine, glasses, phones and other objects they need but have lost. And while the initial focus is on assisting a specific group of people, the technology could someday be used by anyone who has searched high and low for something they’ve misplaced. “The long-term impact of this is really exciting,” said Dr. Ali Ayub, a post-doctoral fellow in electrical and computer engineering. “A user can be involved not just with a companion robot but a personalized ...

Study shows how both metabolically healthy and unhealthy ‘forms’ of obesity increase risk of various obesity-related cancers

2023-05-14

**Note: the release below is a special early release from the European Congress on Obesity (ECO, Dublin, 17-20 May). Please credit the conference if you use this story** New research to be presented at this coming week’s European Congress on Obesity in Dublin, Ireland (17-20 May) and published in the Journal of the National Cancer Institute shows that both the metabolically healthy and unhealthy ‘forms’ of obesity are associated with an increased risk of various obesity-related cancers, with the relationship stronger in metabolically unhealthy obesity. The study is by Dr Ming Sun, Lund University, Malmö, ...

Clinically relevant deficiency of the “bonding hormone” oxytocin demonstrated

2023-05-14

The hormone oxytocin is important for social interaction and to control emotions. A deficiency of this hormone has previously been assumed in various diseases such as autism, but has never been proven. Now, for the first time, researchers from the University of Basel and the University Hospital of Basel have succeeded in demonstrating a deficiency of oxytocin in patients with a deficiency of vasopressin caused by a disease of the pituitary gland. This finding could be key to developing new therapeutic approaches. The hormones oxytocin and vasopressin are produced in the same area of the brain ...

Addiction scientists seek to better understand cocaine use disorder: ‘Stimulants are coming back’

2023-05-14

Nearly 2 percent of the U.S. population reported cocaine use in 2020, and the highly addictive substance was involved in nearly one in five overdose deaths, according to the Centers for Disease Control. In Virginia, the number of cocaine-related overdoses has been increasing since 2013, with 968 fatal overdoses in 2022, according to preliminary data from the Virginia Department of Health, a 20 percent increase over 2021. Of those, four in five included fentanyl — prescription, illicit or analog — a driving force behind the fatalities. Researchers at the ...

University of Kentucky physicians push for standard-of-care opioid treatment for incarcerated patients

2023-05-13

In a recently published commentary, UK HealthCare physicians call for standard-of-care treatment for opioid use disorder (OUD) among patients who are incarcerated. The viewpoint article by Anna-Maria South, M.D., Laura Fanucchi, M.D., and Michelle Lofwall, M.D., published in JAMA April 24 highlights the barriers to initiating medication for opioid use disorder (MOUD) among people who are incarcerated. For patients with opioid use disorder, medications such as buprenorphine and methadone are considered by the medical community as standard of care treatments, as they alleviate withdrawal symptoms, reduce cravings and pain, ...

Fear of childbirth exacerbated by the COVID-19 pandemic

2023-05-13

The COVID-19 pandemic exacerbated fear of childbirth among pregnant people in the U.S., according to a new Dartmouth study. The researchers were particularly interested in understanding, from a U.S. context, which factors predict childbirth fear and how the pandemic has affected this fear and birth outcomes. The findings are published in Evolution, Medicine, and Public Health. "Our results showed really high rates of childbirth fear in our sample," says first author Zaneta Thayer '08, an associate professor of anthropology at Dartmouth. "Since there's no pre-pandemic U.S. data, we cannot compare our data to that context but we know that ...

Restoring control to a particular brain region may help to prevent return to use of opioids

2023-05-13

A team of neuroscientists at the Medical University of South Carolina (MUSC) has identified changes in the activity of brain cells known as pyramidal neurons, which contribute to drug seeking in a preclinical model of opioid use disorder. After access to heroin was stopped, these neurons became more excitable. The activity of these neurons was restored to normal by blocking the enzyme protein kinase A (PKA). Inhibiting this enzyme also reduced opioid-seeking behavior. Jacqueline McGinty, Ph.D., professor of neuroscience, and Saurabh Kokane, Ph.D., a postdoctoral scholar in McGinty’s laboratory, recently published their team’s findings in the Journal of Neuroscience. The risk ...

University of Maryland School of Medicine launches groundbreaking study on THC/CBD therapy for dementia-related agitation at end of life

Targeting stem-property and vasculogenic mimicry for sensitizing paclitaxel therapy of triple-negative breast cancer by biomimetic codelivery

SRSF7 promotes pulmonary fibrosis through regulating PKM alternative splicing in lung fibroblasts

Psychological stress-activated NR3C1/NUPR1 axis promotes ovarian tumor metastasis

[Press-News.org] New deal inked to space test meta-optical surfaces
European Space Agency funds project

New deal inked to space test meta-optical surfaces

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: